Jack Lief

2014

In 2014, Jack Lief earned a total compensation of $3.2M as Former President, Chief Executive Officer and Director at Arena Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$383,456
Option Awards$421,278
Salary$746,750
Stock Awards$1,636,600
Other$16,068
Total$3,204,152

Lief received $1.6M in stock awards, accounting for 51% of the total pay in 2014.

Lief also received $383.5K in non-equity incentive plan, $421.3K in option awards, $746.8K in salary and $16.1K in other compensation.

Rankings

In 2014, Jack Lief's compensation ranked 2,820th out of 13,032 executives tracked by ExecPay. In other words, Lief earned more than 78.4% of executives.

ClassificationRankingPercentile
All
2,820
out of 13,032
78th
Division
Manufacturing
998
out of 4,965
80th
Major group
Chemicals And Allied Products
318
out of 1,690
81st
Industry group
Drugs
248
out of 1,369
82nd
Industry
Pharmaceutical Preparations
205
out of 1,042
80th
Source: SEC filing on April 28, 2016.

Lief's colleagues

We found six more compensation records of executives who worked with Jack Lief at Arena Pharmaceuticals in 2014.

2014

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2014

Steven Spector

Arena Pharmaceuticals

General Counsel

2014

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2014

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2014

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2014

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

You may also like